Compare ADMA Biologics Inc (ADMA) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Moderna, Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Moderna, Inc. trades at $60.5 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 10.9× ADMA Biologics Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | MRNA | |
|---|---|---|
Market Cap | $2.22B | $24.18B |
Sector | Health | Health |
52-Week High | $20.38 | $81.80 |
52-Week Low | $7.60 | $22.36 |
Enterprise Value | $2.29B | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
